Russell Investments Group Ltd. Buys 84,029 Shares of Oscar Health, Inc. (NYSE:OSCR)

Russell Investments Group Ltd. grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 63.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 216,782 shares of the company’s stock after buying an additional 84,029 shares during the period. Russell Investments Group Ltd.’s holdings in Oscar Health were worth $2,914,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the period. BIT Capital GmbH grew its stake in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after purchasing an additional 4,396,872 shares during the period. Hennessy Advisors Inc. grew its stake in shares of Oscar Health by 550.3% in the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. Clearbridge Investments LLC acquired a new position in shares of Oscar Health in the 4th quarter worth approximately $19,088,000. Finally, American Century Companies Inc. lifted its position in shares of Oscar Health by 185.6% during the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company’s stock worth $17,273,000 after buying an additional 835,144 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 2.8 %

Shares of OSCR opened at $12.01 on Friday. The stock has a fifty day moving average price of $13.80 and a two-hundred day moving average price of $15.15. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $3.01 billion, a price-to-earnings ratio of -600.05 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $11.47 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Oscar Health presently has an average rating of “Hold” and an average price target of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.